Drug Approval | August 16, 2023
Lupin's Mandideep Unit-2 facility completes USFDA inspection with no observations
The inspection was conducted from August 7 to August 11, 2023 and concluded without any observations.
The inspection was conducted from August 7 to August 11, 2023 and concluded without any observations.
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023
Krsnaa Diagnostics has reported total income of Rs. 143.80 crores during the period ended June 30, 2023
Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
